Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)

NCT06879886 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06879886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06879886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRD-Guided Surveillance in Resectable Stage IV Metastatic Colorectal Cancer (SURVEILLANCE-II)
Lead sponsor
Fudan University
Phase
Observational
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
July 31, 2028
Enrollment
181 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc), colorectal cancer liver metastases (crlm)